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A Prospective Epidemiological Survey of the Natural History of 
Chronic Critical Leg Ischaemia 
The i.c.a.i. Group (gruppo di studio dell'ischemia cronica critica degli arti inferiori)* 
Istituto di Ricerche Farmacologiche "Mario Negri", Milan, and Centro di Ricerche Farmacologiche e Biomediche 
"Consorzio Mario Negri Sud', Santa Maria Imbaro, Italy. 
Objective: To draw a picture of the different practices adopted for the diagnosis, specific treatment and general care of 
critical leg ischaemia (CLI) in the light of the recommendations of the recent Consensus Document. 
Design: Prospective observational study. 
Setting: A representative sample of vascular and general surgery, angiology, general medicine departments ofthe Italian 
National Health Service. 
Subjects: Patients with leg ischaemia considered as chronic and critical according to the definition and diagnostic riteria 
adopted in each centre. 
Chief outcome measures: Epidemiological profile of the standard population; prevalence of definition criteria and of 
diagnostic and therapeutic procedures; hort and medium-term clinical outcome as well as of the general vascular morbidity 
and mortality. 
Main results: Over a 3 month period, 574 patients were recruited in 69 centres mainly on the basis of clinical findings 
of CLI (rest pain and~or t ophic lesions). They had an adequate diagnostic assessment oftheir vascular lesions and a high 
cardiovascular risk in terms of prior morbidity and presence of risk factors. Over half of the patients underwent 
revascularisation a d three quarters were given pharmacological treatments. At the end of the observation period, 50 
patients had died (8.7%), three had had a myocardial infarction (0.5%), six a stroke (1.0%), 70 a major amputation (12.2%) 
and 103 had persistent CLI (17.9%). 
Conclusions" This survey confirms the dramatic prognosis of patients with CLI and provides an appropriate background 
and setting to conduct experimental clinical studies in this field. 
Key Words: Epidemiology; Peripheral vascular disease; Critical leg ischaemia. 
Introduction 
Chronic critical eg ischaemia (CLI) is still an "orphan" 
disease with respect to the availability of reliable 
epidemiological data and standardised clinical 
approaches. The reasons may be sought both in the 
complexity of the disease itself and in the number of 
pathogenetic mechanisms involved, as well as in the 
uncertainties existing with respect o the effectiveness 
of the currently available therapeutic interventions. 
Recently CLI has been awarded some attention due 
to the publication of two Consensus Documents by the 
European Working Group on Chronic Critical Leg 
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Ischaemia. 1"~ It seemed useful to address the many 
unsettled issues of CLI in order to draw a reliable 
profile of the different procedures and interventions 
adopted in the diagnosis and in the treatment 
of CLI, and to obtain quantitative vidence on the 
practicability of the measures recommended by the 
Consensus Documents. This epidemiological 
approach was also undertaken with a view to identify- 
ing sizeable populations of patients as potential 
candidates for controlled clinical trials of various 
interventions. 
Methods 
About 100 centres involved in the care of CLI in Italy 
(vascular and general surgery as well as angiology 
and medical departments) were identified and invited 
to a seminar to discuss the main statements of the 
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most recent Consensus Document. 2 An epidemio- 
logical survey was proposed in order to describe the 
characteristics and clinical outcome of patients with 
CLI and to evaluate the consistency of the diagnostic 
and therapeutic practices with those recommended by 
the European Consensus. 
For each patient admitted to each centre with a 
diagnosis of documented leg ischaemia considered as 
"chronic and critical" according to local criteria, a 
monitor recorded the following information: demo- 
graphic data, previous clinical history including cardi- 
ovascular events, time of onset of peripheral disease 
and presence of major cardiovascular isk factors; 
characteristics of the symptoms and signs qualifying 
the ischaemia as chronic and critical; diagnostic 
procedures undertaken; number, side(s) and level(s) of 
vascular obstruction(s); invasive procedures and/or  
pharmacological treatments; major amputations and 
relevant clinical events including death. 
All patients were admitted sequentially and were 
recruited over two predefined 45 day periods in 
different seasons (May-June and October-November). 
For each patient enrolled a follow-up visit was 
planned 3 months after hospital discharge (regardless 
of the length of hospitalisation) to document survival 
or report the date and cause of death and to record 
major amputations, persistence of CLI, and any 
treatment undertaken following discharge from the 
index admission. For patients lost to follow-up mortal- 
ity data have been obtained through census offices. 
Auditing was provided by a central secretariat, 
assessing the consistency and completeness of the data 
reported for each patient. Standard descriptive statis- 
tics were used to report study results. Since obviously 
contraindicated by the descriptive nature of the study, 
none of the apparent differences among subgroups of 
the study population have been formally tested for 
statistical significance. 
Results 
Recruitment and follow-up 
Sixty-nine centres - -  49 vascular surgery (71.0%) and 
20 angiology (29.0%) departments--part ic ipated. 
Five hundred and seventy four patients were classi- 
fied as having a critical ischaemia of the lower limbs. 
Each centre recruited an average of 8.4 patients (range 
1-36). Surgical centres recruited 75.3% of the overall 
study population (432 patients). 
The average observation period, including the 
hospital phase was 26.2 + 19.7 days (median 20.5 days) 
and the 3-month follow-up, was 102.9+45.5 days 
(median 109 days). Complete follow-up information 
was obtained on 507 patients (88.3%). The group of 
sixty-seven patients (11.7%) lost to follow-up did not 
substantially differ from the overall study population 
with respect o age, prevalence of diabetes, incidence 
of previous and in-hospital cardiovascular events and 
amputations, and unsuitability for surgery. Some 
informations were nonetheless available for all but six 
patients of this group: 60 out of 61 were alive at 3 
months after discharge, eight had suffered from an in- 
hospital event (seven amputations and one myocar- 
dial infarction) and one patient died within 3 months 
of discharge. 
Baseline characteristics 
The mean age was 70.8 ( + 9.7 S.D.; median 70.7; range 
34-91) (Table 1). Three quarters of the subjects 
(431/574, 75.1%) were male. The majority (496, 86.4%) 
had a history of intermittent claudication diagnosed 
over the previous 2 years in two-thirds of the patients 
(322, 64.9%) and in the previous year in over one-third 
(185, 37.3%). One third of the patients had already 
undergone invasive interventions: 9.4% amputation 
Table 1. Baseline characteristics of the study population overal' 
and according to admission to surgical or medical wards 
Surgical Medical 
Total wards wards 
n=574 n=432 n=142 
Age: mean + S.D. 70.8+9.7 70.3+9.6 72.3_+10.0 
median 70.7 70.2 72.7 
n (~) 
Sex (male) 431 (75.1) 330 (76.4) 101 (71.1) 
Previous cardiovascular morbidity: 
Myocardial infarction 105 (18.3) 68 (15.7) 37 (26.1) 
Stroke 58 (10.1) 39 (9.0) 19 (13.4) 
Claudicatio ntermittens 496 (86.4) 379 (87.7) 117 (82.4) 
Previous urgical interventions: 
Reconstructive surgery 109 (19.0) 99 (22.9) 10 (7.0) 
PTA 21 (3.7) 15 (3.5) 6 (4.2) 
Amputation 54 (9.4) 39 (9.0) 15 (10.6) 
-major 32 (5.6) 25 (5.8) 7 (4.9) 
-minor 22 (3.8) 14 (3.2) 8 (5.6) 
Risk factors: 
Arterial hypertension 328 (57.1) 245 (56.7) 83 (58.5) 
Diabetes mellitus 170 (29.6) 124 (28.7) 46 (32.4) 
Hypercholesterolemia 85 (14.8) 73 (16.9) 12 (8.5) 
Obesity 35 (6.1) 28 (6.5) 7 (4.9) 
Smoking 
- past 272 (47.4) 211 (48.8) 61 (43.0) 
- current 141 (24.6) 108 (25.0) 33 (23.2) 
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Table 2. Clinical picture of CLI at recruitment 
Surgical Medical 
Total wards wards 
n=554" n=417 n=137 
Pain ~ 15 days 485 (87.5) 368 (88.2) 117 (85.4) 
Use of analgesics a 15 days 343 (61.9) 262 (62.8) 81 (59.1) 
Ulcers or gangrene 352 (63.5) 269 (64.5) 83 (60.6) 
Others 129 (23.3) 85 (20.4) 44 (32.1) 
n (~). 
*20 patients with missing data. 
(5.6% major, 3.8% minor); 19.0% reconstructive sur- 
gery (more common among patients admitted to 
surgical departments) and 3.7% percutaneous trans- 
luminal angioplasty (PTA). 
A history of myocardial infarction was reported for 
105 patients (18.3%; 15.7% of those admitted to 
surgical departments and 26.1% of those admitted to 
medical departments), while 58 patients had had a 
stroke (10.1%). Arterial hypertension (defined as sys- 
tolic blood pressure > 160mmHg and/or  diastolic 
blood pressure ~ 95 mmHg, or presence of anti- 
hypertensive treatment), was the most common 
(57.1%) cardiovascular risk factor. Almost one third of 
the patients (29.8%) were diabetic (fasting serum 
glucose levels ~ 7.8 mmol/1 (140 mg/dl)  or ongoing 
treatment with insulin or oral hypoglycaemic agents); 
a quarter (24.7%) were current smokers, and half of 
the patients (47.6%) were ex-smokers. Hypercholester- 
olaemia (serum total cholesterol levels _~ 6.4 mmol/1 
(250 mg/dl)  or ongoing cholesterol-lowering treat- 
ment) was present in 14.8% of the patients, partic- 
ularly among those admitted to surgical departments 
(16.9% vs. 8.5% in medical wards). Seven percent of 
the patients were obese (body mass index-[(body 
2 weight in Kg) / (height in m) ] = ~ 30). 
Clinical picture of CLI 
The clinical picture of CLI at the time of recruitment is 
reported in Table 2. Recurrent rest pain lasting for at 
least 15 days was the most common symptom (87.5%) 
and analgesic drugs had been prescribed to 61.9% of 
the patients. Trophic lesions were present in 63.5% of 
subjects and in 315 patients (56.9%) the trophic lesions 
were associated with recurrent rest pain. Only a 
minority of patients (5.8%) were considered "critical" 
even though they did not present rophic lesions or 
recurrent rest pain lasting for at least 15 days. A 
number of other factors (such as low ankle systolic 
pressure, or low ankle brachial pressure index) were 
Table 3. Diagnostic procedures performed uring hospital stay 
Surgical Medical 
Total wards wards 
n=574 t~=432 n=142 
Doppler sonography* 519 (90.4) 395 (91.4) 124 (87.3) 
Angiography 443 (77.2) 374 (86.6) 69 (48.6) 
Doppler and /or 
angiography 561 (97.7) 425 (98.4) 136 (95.8) 
Others: 
Eco Dopplert 196 (34.1) 128 (29.6) 68 (47.9) 
Pletismography 73 (12.7) 28 (6.5) 45 (31.7) 
Capillaroscopy 19 (3.3) 3 (0.7) 16(11.3) 
tcp02 56 (9.8) 35 (8.1) 21 (14.8) 
Laser Doppler 37 (6.4) 22 (5.1) 15 (10.6) 
n (%). 
*M-mode, continuous wave Doppler, 
tDuplex or color Doppler. 
deemed to indicate the presence of a critical condition 
in patients with no ulcer and a shorter history of rest 
pain. 
Ankle or toe systolic pressures were measured in 
341 (59.4%) patients. A systolic pressure < 50mmHg at 
the ankle and/or  < 30mmHg at the toe was reported 
in 182 subjects (53.4% of those in whom it was 
measured). The resting ankle brachial pressure index 
(ABPI) was available for 243 patients. ABPI was < 1 in 
all but one of these subjects; < 0.7 in 230 (94.6%); < 0.5 
in 201 (82.7%). Among non-diabetic patients (173, 
71.2%) ABPI was < 0.7 in 161 (93.1%) and < 0.5 in 146 
(84.4%). Among diabetics (70, 28.8%) it was < 0.7 in 68 
(97.1%) and < 0.5 in 55 (78.6%). 
Doppler waveform analysis was the most widely 
used diagnostic procedure (90.4% of the patients) 
(Table 3). Over three-quarters of the patients under- 
went angiography, more often in surgical (86.6%) than 
in medical (48.6%) departments. Almost all patients 
(97.7%) underwent one or both diagnostic procedures. 
More sophisticated diagnostic tests, particularly those 
evaluating the peripheral microcirculation, were less 
commonly used, and mostly in medical 
departments. 
Only four patients (0.7% of the study population) 
did not suffer from a vascular obstruction. Single 
lesions were found in 85 patients (14.8%), 57 of whom 
had a proximal obstruction (i.e. above the knee). Of 
the patients presenting more than one lesion, 392 
(68.3%) had multiple obstructions: 137 (23.9%) in the 
thigh, 176 (30.7%) in the leg, and 79 (13.8%) in both 
segments. In 181 patients (31.5%) both lower limbs 
were affected: 100 (17.4%) at thigh level, 26 (4.5%) at 
leg level, and 25 (4.4%) at both segments. One half of 
these patients (90) had multiple obstructions in both 
limbs. 
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Treatment 
Interventional procedures were performed uring the 
hospital stay in over half (330, 57.5%) of the patients 
(Table 4). Reconstructive surgery was the most com- 
mon treatment: 34.0% and 7.7% of the patients 
underwent bypass grafting and thromboendoarter- 
ectomy respectively. These interventions were almost 
exclusively performed in patients admitted to surgical 
centres. Percutaneous transluminal angioplasty was 
less commonly undertaken (7.1% of the patients); 
surgical sympathectomy was used in 9.5% of the cases, 
epidural spinal electrostimulation in 3.8% and minor 
amputations in 5.2%. Invasive procedures were car- 
ried out on 68.5% of patients admitted to surgical 
departments (296/432 patients) and on 23.9% of those 
admitted to medical departments (34/142). 
The wider adoption of surgery among those admit- 
ted to surgical departments is largely explained by the 
referral of patients to either surgical or medical 
centres, according to their clinical picture and suit- 
ability for intervention. For 38 surgical patients (8.8%) 
revascularisation procedures (bypass grafting, throm- 
boendoarterectomy, PTA) were considered unsuitable 
on the basis of their general clinical conditions, 62 
(14.4%) of peripheral circulation conditions, and 16 
(3.7%) for both reasons. For 38 medical patients 
(26.8%) revascularisation procedures were considered 
unsuitable on the grounds of their general clinical 
conditions, 33 (23.2%) of peripheral circulation condi- 
tions and 6 (4.2%) for both reasons. Immediate 
revascularisation was deemed unnecessary in 68 
(15.7%) and 34 (23.9%) surgical and medical patients 
respectively. 
Three-quarters of the patients (429, 74.7%) (Table 5) 
received a pharmacological treatment; drug treat- 
ments were used alone or with revascularisation 
procedures. Over half were treated with vasoactive 
drugs; also drugs interfering with the haemostatic 
system (heparin, antiplatelet agents, defibrotide) were 
widely used. Prostanoids were administered to 5.2%. 
Table 4. Inpatient interventional treatments 
Surgical Medical 
Total wards wards 
n=574 n=432 n=142 
Bypass 195 (34.0) 185 (42.8) 10 (7.0) 
Thromboendoarterectomy 44 (7.7) 44 (10.2) 0 (0.0) 
PTA 41 (7.1) 30 (6.9) 11 (7.8) 
Sympathectomy 55 (9.6) 45 (10.4) 10 (7.0) 
Epidural spinal 
electrostimulation 22 (3.8) 18 (4.2) 4(2.8) 
Minor amputation 30 (5.2) 25 (5.8) 5 (3.5) 
n (%). 
Table 5. Inpatient pharmacological treatments 
Surgical Medical 
Total wards wards 
n=574 n=432 n=142 
Vasoactive drugs 296 (51.6) 187 (43.3) 109 (76.8) 
Heparin and heparinoids 215 (37.5) 149 (34.5) 66 (46.5) 
Antiplatelet agents 120 (20.9) 76 (17.6) 44 (31.0) 
Defibrotide 60 (10.5) 44 (10.2) 16 (11.3) 
Fibrinolyticagents 31 (5.4) 27 (6.3) 4 (2:8) 
Prostanoids 30 (5.2) 22 (5.1) 8 (5.6) 
Haemodilutingagents 22 (3.8) 19 (4.4) 3 (2.1) 
Others 63 (11.0) 41 (9.5) 22 (15.5) 
n (%). 
Vasoactive drugs, antiplatelet agents and heparinoids 
were more frequently used in medical departments; in 
contrast, thrombolysis was mainly performed by 
surgeons. Other procedures, uch as peridural anaes- 
thesia, lumbar chemical sympathectom)~ isovolemic 
haemodilution, hyperbaric oxygen therapy were used 
in a minority. 
Outcome 
Fifty patients (8.7%) died during the observation 
period (Table 6). The deaths were mainly due to 
vascular causes (29 vs. 9 non-vascular deaths; in 11 
cases the cause of death was not reported). About ½ of 
the deaths (26; 53.1%) occurred during the hospital 
phase, 6 of which (12.2%) were within the first week of 
hospitalisation. Acute myocardial infarctions and 
strokes were less frequent: (2.3 and 3.1%, respectively); 
two-thirds (20 out of 31) were fatal events or occurred 
in patients who subsequently died. 
During the whole study period 84 (14.6%) patients 
underwent major amputations (Table 6). Fourteen 
amputees subsequently died. Most of the amputations 
(53, 62.4%) were performed uring the hospital phase, 
14 (16.7%) within the first week of admission. 
Although the incidence of major amputations during 
the index hospitalisation was higher in surgical wards, 
over the entire observation period the highest inci- 
dence was among patients admitted to medical wards. 
Rest pain and/or ulcers or gangrene were still present 
in 103 (17.9%) patients at follow-up. In addition, 11 
amputees developed pain and/or ulcer of the other 
leg. Therefore, over two-thirds of the survivors not 
undergoing amputation had recovered from their 
critical status. 
The overall evaluation of clinical outcomes is 
presented in Table 7. It is noteworthy that only 286 
patients (49.8%) were alive, did not suffer from any 
major event and had recovered from CLI 3 months 
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Table 6. Major clinical events occuring during hospitalisation and after discharge 
In hospital After Discharge Total 
Surgical Medical Surgical Medical Surgical Medical 
Total wards wards Total wards wards Total wards wards 
(n=574) (n=432) (n=142) (n=542)* (n=382) (n=125) (n=574) (n=432) (n=142) 
Death 26 (4.5) 18 (4.2) 8 (5.6) 24 (4.5) 18 (4.7) 6 (4.8) 50 (8.7) 36 (8.3) 14 (9.9) 
Major amputation 53 (9.2) 38 (8.8) 15 (10.6) 32 (6.3) 20 (5.2) 12 (9.6) 85 (14.8) 58 (13.4) 27 (19.0) 
Myocardial infarction 6 (1.0) 5 (1.2) 1 (0.7) 7 (1.4) 6 (1.6) 1 (0.8) 13 (2.3) 11 (1.9) 2 (1.4) 
Stroke 8 (1.4) 6 (1.4) 2 (1.4) 10 (2.0) 8 (2.1) 2 (1.6) 18 (3.1) 14 (3.2) 4 (2.8) 
n (%). 
*Indudes all patients but those who died during the in-hospital phase (n=26) and those (n=6) for whom no information was available at 
foUow-up. 
Patients who suffered multiple vents are counted more than once. 
In three patients the same vent occured twice (two amputations, two myocardial infarctions, two strokes respectively) during the study 
period. 
after discharge. As many as 177 survivors (30.8%) 
became amputees and/or  had persistent critical 
ischaemia of the lower limbs. Moreover, though alive 
at 3 months, nine patients (1.6%) had suffered from a 
myocardial infarction or a stroke. In summary out of 
574 CLI patients 3 months after discharge, 50 subjects 
(8.7%) had died and 181 (31.5%) had experienced at 
least one major vascular event (myocardial infarction 
or stroke) and/or  had undergone major amputation 
and/or  were sti l l  suffering from critical ischaemia 
(Table 7). 
Discussion 
This is the first large epidemiological study conducted 
since the publication of the last European Consensus 
Table 7. Clinical outcome 3 months after discharge 
Surgical Medical 
Total wards wards 
(n=574) (n=432) (n=142) 
Dead 50 (8.7) 36 (8.3) 14 (9.9) 
Alive 
Without major events or 
persistent CLI 286 (49.8) 225 (52.1) 61 (43.0) 
With persistent CLI 
without other events 103 (17.9) 75 (17.4) 28 (19.7) 
With major amputation 
regardless of other 
events 70 (12.2) 47 (10.9) 23 (16.2) 
With myocardial infarction 
or stroke, regardless 
of persistent CLI/ 
major amputation* 9 (1.6) 6 (1.4) 3 (2.1) 
n (5). 
*Four patients uffered only from myocardial infarction (n=3) or 
stroke (n=l). Four patients with persistent CLI and an amputee had a 
stroke. 
Document on CLI 2 and the data presented provides an 
updated profile of CLI to compare with that suggested 
by the Consensus. According to the study aims, the 
results are discussed under two main headings: (a) the 
clinical profile of the disease and (b) the quality and 
setting-dependent variability of diagnostic riteria and 
treatment. 
Clinical profile 
The clinical profile outlined indeed confirms the 
severity of the condition, both in terms of mortality 
and of serious complications in the short term. At the 
end of the 3 month follow-up period, 40.2% had either 
died or suffered from a myocardial infarction, a stroke, 
a major amputation and/or  persistent CLI. The only 
positive note comes from survivors not undergoing 
amputation, since their odds of recovering from CLI, 
i.e. of reaching ulcer healing and pain relief, are 2 in 
3. 
The more favourable outcome of patients admitted 
to surgical department as compared with those of 
medical wards is likely to be due to their different 
prognosis at the time of admission rather than to the 
general care and specific interventions provided in the 
two settings. The slight difference in mortality 
between surgical and medical wards is attributable to 
the preferential admission to medical departments of
patients unsuitable for surgery on the grounds of their 
poor general conditions, regardless of the peripheral 
vascular situation (31.0% of the medical patients vs. 
12.5% of the surgical cases). The striking difference in 
the amputation rate may be due to similar reasons: 
patients unsuitable for reconstructive surgery are 
more likely to be admitted to medical departments for 
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alternative therapeutic strategies until amputation 
becomes unavoidable. Indeed, the only excess of 
amputation reported in surgical wards compared to 
the medical ones (14 vs. none) concerns the operations 
performed within one week from admission, i.e. those 
which could not be delayed. 
Quality of care 
Patients with CLI were identified on the basis of their 
clinical picture. Indeed, among the criteria suggested 
by both the European Consensus 2 and the IVS 
Working Party, 3 those more closely adhering to the 
clinicians' concept of a critical peripheral situation 
seem to be the clinical ones (e.g. presence of rest pain 
for at least 2 weeks regardless of concomitant use of 
analgesics and/or trophic lesions). These criteria 
apply to almost all the patients recruited in this study. 
In contrast, the simultaneous presence of low periph- 
eral systolic pressure, as suggested by the Consensus 
recommendations, would have restricted the diag- 
nosis of CLI to less than 20% of the patients, who 
nonetheless from a clinical point of view were deemed 
"critical". This parameter is in fact neither widely 
measured nor necessarily altered in patients with CLI: 
indeed, the systolic pressure at the ankle or toe was 
only measured in about half of the patients, and only 
½ of these had values below the standard threshold 
indicated by the Consensus. The inclusion among 
diagnostic riteria of the concomitant use of analge- 
sics, the presence or absence of which does not 
necessarily define the symptoms' nature and degree, 
would have restricted the diagnosis of CLI to 80% of 
the study population. Though recognised as a pre- 
dictor of total mortality (not only of vascular deaths) 4's 
and since long recommended as the simplest measure 
to detect arterial disease of the lower limbs, 6 ABPI is 
considered less relevant as a diagnostic riterion than 
absolute ankle pressure in patients with CLI z possibly 
being more useful in the assessment of early stages of 
peripheral artery disease. In this study ABPI was 
evaluated in about ½ of the cases, and four-fifths of the 
patients had values of 0.5 or less. The assessment of
the criteria adopted in each centre to classify limbs as 
"critical" aimed at establishing a standard reference 
shared by the members of the collaborative group, to 
be used in epidemiological nd clinical studies. The 
choice of a simple clinical definition of CLI may 
overcome a limitation of those currently recom- 
mended because although they may be useful for 
identifying subgroups at higher isk of amputation or 
death, 3 they are of doubtful clinical usefulness. 
Indeed, patients with different manifestations of the 
disease ultimately share the same clinical outcome, 
and no treatment has been proved effective in improv- 
ing the prognosis of any subgroup at risk. On the other 
hand, in contrast with the Consensus suggestion, 
simple definition criteria are more adequate for 
clinical trials addressing general questions concerning 
the population of patients with CLI. This approach 
would ensure awider applicability ot~the trials results, 
whilst allowing the identification of particular sub- 
groups. Arteriograph); recommended by the Euro- 
pean Consensus 2 among the diagnostic procedures for 
all patients with CLI, was performed in three-quarters 
of patients, more commonly in surgical than in 
medical centres. However, almost all patients under- 
went either arteriography or Doppler analysis, which 
documented an arterial obstruction or stenosis in all 
but four patients. 
Over half of the patients underwent invasive inter- 
ventions, mostly bypass grafting procedures. Throm- 
boendoarterectomy and PTA were rarely performed. 
The scanty involvement of interventional radiologists, 
and the lack of wide expertise and of appropriate 
facilities may have limited the use of less invasive 
procedures such as angioplasty. Although wider use 
of endovascular techniques i  encouraged in agree- 
ment with the general trend favouring non-invasive 
intervention procedures, 7'8the Consensus recommen- 
dation to attempt percutaneous catheter procedures 
whenever possible 2 as a first choice must be regarded 
in the light of reports questioning the effectiveness of 
angioplasty with respect o avoiding amputation or 
reconstructive intervention. 9 Patients admitted to sur- 
gical departments underwent intervention more often, 
as a result of their clinical condition and their 
suitability for surgery Indeed, only a quarter (116, 
26.9%) of surgical patients as compared with over half 
(77, 54.2%) of the medical ones were considered 
unsuitable for surgery. On t-he other hand, inter- 
vention was considered unnecessary in 68 (15.7%) and 
in 34 (23.9%) surgical and medical patients 
respectively. 
The pharmacological treatments undertaken in 
three-quarters of the patients involved several classes 
of drugs and reflects the existing uncertainties 
on the efficacy of available medications and of the 
impact of market pressures. This is a situation 
clearly requiring further clinical research, as already 
stated in the Consensus Document. 2 Over half of the 
patients were treated with vasoactive drugs, regard- 
less of the widespread oubts on their efficacy. 1° 
Heparin and heparinoids were commonly used, 
though not as commonly as recommended by the 
Consensus regarding thromboprophylaxis given the 
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high frequency of surgical interventions. Although the 
current use of heparin in surgical patients may 
represent an adequate practice (as documented by an 
ad hoc study recently performed in Italyl~), it is 
noteworthy that this treatment was more common in 
medical than in surgical centres. Antiplatelet agents 
were only given to one-fifth of patients. This may 
indicate underprescription in the light of the high 
cardiovascular risk of these patients and of the 
general ~z'13 and specific 14 usefulness of these drugs. 
Thrombolysis for CLI was rarely attempted, in accor- 
dance with the recommendations of the European 
Consensus, which has increasingly imited the indica- 
tions for this pharmacological approach. 1'2 Defibrotide 
was widely used despite the lack of definite proofs of 
efficacy. 15 Prostanoids, which had not been introduced 
onto the Italian market when the study was per- 
formed, were only used in a small fraction of the study 
population, compared to the recommendations of the 
Consensus, 2 based on their promising pharmaco- 
logical properties 16and preliminary clinical findings 
of efficac3z 17 
Besides drawing an accurate picture of the charac- 
teristics of patients with CLI and of the current clinical 
procedures adopted, this study documents he interest 
of clinicians involved in the management of these 
patients in the epidemiology of the condition. Over 
100 centres in Italy were willing to take part in a 
collaborative group and 69 actually contributed to the 
preliminary epidemiological survey. The importance 
of the i.c.a.i, study is also related to the demonstration 
of the feasibility of randomised clinical trials in 
populations of CLI patients large enough to allow the 
assessment of effectiveness of interventions on hard 
endpoints uch as mortality and major clinical events. 
A collaborative clinical trial conducted by the i.c.a.i. 
group aiming to recruit 2000 patients is currently 
under way. 
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Appendix: 
The i.c.a.i. Group was represented by: 
Participating Centres: Belgrano E.A. and Nardella L., 
Vascular Surger~ Santa Croce Hospital, Cuneo; Pon- 
zio E and Nessi E, Vascular Surgery, Molinette 
Hospital Torino; Guala A. and Mazzucchetti S., 
Angiology and Geriatrics, Infermi Hospital, Biella; 
Graziano L. and Urban I., General Surgery, SS. Trinita 
Hospital, Varallo Sesia; Palombo D. and Brustia P., 
Vascular Surgery and Angiolog~ Regionale Hospital, 
Aosta; Calzoni D., Bellone M. and Altieri M., General 
Surgery, S. Carlo Hospital Milano; Agus G.B., De 
Angelis R. and Marrocu R., Vascular Surgers~ Santa 
Rita Clinic, Milano; Grossi A. and Frigerio D., General 
Surgery, San Raffaele Hospital, Milano; Biasi G.M. 
and Piglionica M.R., Vascular SurgerN Bassini Hospi- 
tal Milan; Agrifoglio G., Costantini A., Della Vedova 
MR. and Miglierina L., Vascular Surgery and Angiol- 
ogy, Istituti Clinici di Perfezionamento, Milano; Lavor- 
ato E, Emanuelli G., Rossi R. and Flandoli C., 
General Surgery, S. Gerardo dei Tintori Hospital 
Monza; Ponti G.B. and Berra S., General Medicine, 
Rho Hospital Rho; Losapio G.M. and Ambrosi R., 
Vascular SurgerN Ospedali Riuniti, Bergamo; Inzoli 
M.R., Lombardi G., Tarantola P. and Zocca N., 
Geriatric and Rehabilitation Unit, S. Orsola Hospital, 
Brescia; Sforza M. and Russo R., General SurgerN 
Lecco Hospital, Lecco; Tenchini P. and Bruni T., 
General Surgery I, Carlo Poma Hospital Mantova; 
Fontanili M. and Guidetti D., General Surgery II, 
Carlo Poma Hospital, Mantova; Odero A. and Salvini 
M., Vascular Surgery, San Matteo Hospital, Pavia; 
Pedeferri G. and Bordoni M.C., Vascular Surgery, 
Bormio and Sondalo Hospital, Sondalo; Visconti W. 
and Vedovato E, Vascular SurgerN G.B. Giustinian 
Hospital Venizia; Bittolo Bon G. and Maffei L., 
General Medicine, Civile Hospital Venizia; Marcon G. 
and Dell'Olivo I., General Medicine, Angiology and 
General Surger3~ Mirano Hospital Mirano; Gracco L. 
and Petralia G., General Surgery, Umberto I Hospital 
Mestre; Cordiano C. and Dorucci V., General Surgery, 
Borgo Trento Hospital Verona; Pagnan A. and Visona' 
A., Internal Medicine, Castelfranco V.to; Tonietto G. 
and Agresta E, General Surger~ Civile Hospital, 
Vittorio V.to; Favretti E and Burigo E., General 
Surgery, Presidio Hospital Belluno; Giansante C. and 
Fiotti N., General Medicine, Cattinara Hospital 
Trieste; Pamich G. and Santirocco C., Vascular Sur- 
gers~ Civile Hospital Gorizia; Mozzon L. and Gonano 
N., Vascular Surger~ S. Maria della Misericordia 
Hospital Udine; Petrilli G.L., Puzzo A. and Baldinog 
G., Vascular Surger~ Galliera Hospital Genova; 
Podest~ A., Guastini A. and Traversaro A., General 
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Surgery, Lavagna Hospital Lavagna; Zinicola N. and 
Baglietto F., Vascular Surgery Santa Corona Hospital 
Pietra Ligure; Borgatti E., Filippini M. and Ferrari E, 
Angiology, Malpighi Hospital Bologna; Ridolfi, 
Angiology and General Medicine, Maggiore Hospital 
Bologna; Coppi G. and Camparini S., Vascular Sur- 
gery, San Agostino Hospital Modena; Tuscano G. and 
Lonardi R., Vascular Surgery Policlinico Modena; 
Botta G.C., Banchini E. and Pavarini E., General 
Surgery, Maggiore Hospital, Parma; Delmonte E. and 
Bucherini E., Geriatrics, Per gli Infermi Hospital 
Faenza; Moratti A. and Ieran M., general Medicine 
and Angiology, S. Maria Nuova Hospital, Reggio 
Emilia; Bertini D. and Pratesi C., Vascular Surgery, 
Ca~'eggi Hospital Firenze; Corsi C., Pollastri M. and 
Marrapodi E., Angiology, Santa Chiara Clinic, Firenze; 
Vanni D. and Ralli L., Internal Medicine, Centrale 
Hospital, Arezzo; Cecchi M., Vascular Surgery Cen- 
trale Hospital Arezzo; Bigalli A. and Del Carratore 
G., Cardiovascular Medicine, Santa Chiara Hospital, 
Pisa; Mosca E and Vatteroni F., Vascular Surgery, 
Cisanello Hospital, Pisa; Setacci C., Vascular Surgery, 
Le Scotte Hospital, Siena; Cao P. and Verzini F., 
Vascular Surgery, Monteluce Hospital, Perugia; Man- 
narino E., Pasqualini L. and Fedeli E, General 
Medicine and Angiolog36 Monteluce Hospital Per- 
ugia; Alo" E and Ioannidis G., Vascular Surgery, 
Torrette Hospital, Ancona; Spartera C. and Marino G., 
Vascular Surger)9 San Salvatore Hospital, L'Aquila; 
Medori M., General Surgery, Civile Hospital Giulia- 
nova; Pola P. and Dal Lago A.A., Angiology, Gemelli 
Hospital, Roma; Di Giovanani V. and Colli R., 
Vascular Surger)4 Gemelli Hospital Roma; Man- 
iscalco G., General Medicine and Angiology, Filippo 
Neri Hospital, Roma; Bartolo M. and Todini A.R., 
Angiolog~ San Camillo Hospital, Roma; Benedetti- 
Yalentini E and Irace L., Vascular Surgery, Umberto I 
Hospital Roma; Fiorani P. and Taurino M., Vascular 
Surger)~ San Eugenio Hospital Roma; Marcialis A. 
Vascular Surgery, Policlinico, Napoli; Valitutti P. and 
Vigliotti G., Vascular Surgery, San Giovanni di Dio e 
Ruggi d'Aragona Hospital, Salerno; Regina G., Full- 
one M. and Rizzo S., Vascular Surgery, Policlinico, 
Bari; Rolli E and Pascali M., Vascular Surgery, Di 
Summa Hospital Brindisi; Lucentini L., Grilli M. and 
Correra H., Internal Medicine and Angiology, Sollievo 
della Sofferenza Clinic, San Giovanni Rotondo; Flor- 
ena M. and Cassina I., Vascular Surgery Paolo 
Giaccone Hospital Palermo; Notarbartolo A. and 
Belvedere M., Internal Medicine and Geriatrics, Paolo 
Giaccone Hospital, Palermo; Andreozzi G.M., Di 
Pino L., Martini R. and Signorelli S., Angiology, 
Garibaldi Hospital, Catania; Cavallaro S. and Puleo 
R., Vascular Surgery Garibaldi Hospital, Catania; 
Romeo S., Cormaci O.F., Costanzo C. and Grasso A., 
Vascular Surgery, Garibaldi Hospital, Catania. Scien- 
tific and Organising Secretariat: Avanzini F., Bedoni P., 
Bellone M., Bertele' V., Colombo F., Costantini A., 
Fellin G., Pangrazzi J., Roncaglioni M.C., Samori G., 
Tognoni G. Policy Board: Agrifoglio G., de Gaetano 
G., Garattini S., Tognoni G. 
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